QuidelOrtho Statistics
Total Valuation
QuidelOrtho has a market cap or net worth of $2.31 billion. The enterprise value is $4.94 billion.
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
QuidelOrtho has 67.45 million shares outstanding. The number of shares has increased by 0.60% in one year.
| Current Share Class | 67.45M |
| Shares Outstanding | 67.45M |
| Shares Change (YoY) | +0.60% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.37% |
| Owned by Institutions (%) | 101.06% |
| Float | 60.93M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 14.65 |
| PS Ratio | 0.84 |
| Forward PS | 0.84 |
| PB Ratio | 0.79 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 28.35 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.77 |
| EV / EBITDA | 9.34 |
| EV / EBIT | 63.60 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.22, with a Debt / Equity ratio of 0.90.
| Current Ratio | 1.22 |
| Quick Ratio | 0.55 |
| Debt / Equity | 0.90 |
| Debt / EBITDA | 4.61 |
| Debt / FCF | n/a |
| Interest Coverage | 0.41 |
Financial Efficiency
Return on equity (ROE) is -51.36% and return on invested capital (ROIC) is 0.73%.
| Return on Equity (ROE) | -51.36% |
| Return on Assets (ROA) | 0.65% |
| Return on Invested Capital (ROIC) | 0.73% |
| Return on Capital Employed (ROCE) | 1.43% |
| Revenue Per Employee | $421,652 |
| Profits Per Employee | -$310,909 |
| Employee Count | 6,600 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 2.69 |
Taxes
| Income Tax | -79.50M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.70% in the last 52 weeks. The beta is 0.10, so QuidelOrtho's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | -27.70% |
| 50-Day Moving Average | 40.17 |
| 200-Day Moving Average | 40.41 |
| Relative Strength Index (RSI) | 36.88 |
| Average Volume (20 Days) | 852,012 |
Short Selling Information
The latest short interest is 4.39 million, so 6.51% of the outstanding shares have been sold short.
| Short Interest | 4.39M |
| Short Previous Month | 4.26M |
| Short % of Shares Out | 6.51% |
| Short % of Float | 7.21% |
| Short Ratio (days to cover) | 5.55 |
Income Statement
In the last 12 months, QuidelOrtho had revenue of $2.78 billion and -$2.05 billion in losses. Loss per share was -$30.54.
| Revenue | 2.78B |
| Gross Profit | 1.29B |
| Operating Income | 77.60M |
| Pretax Income | -1.99B |
| Net Income | -2.05B |
| EBITDA | 528.30M |
| EBIT | 77.60M |
| Loss Per Share | -$30.54 |
Full Income StatementBalance Sheet
The company has $99.60 million in cash and $2.68 billion in debt, giving a net cash position of -$2.58 billion or -$38.28 per share.
| Cash & Cash Equivalents | 99.60M |
| Total Debt | 2.68B |
| Net Cash | -2.58B |
| Net Cash Per Share | -$38.28 |
| Equity (Book Value) | 2.98B |
| Book Value Per Share | 44.35 |
| Working Capital | 220.10M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $83.00 million and capital expenditures -$195.10 million, giving a free cash flow of -$112.10 million.
| Operating Cash Flow | 83.00M |
| Capital Expenditures | -195.10M |
| Free Cash Flow | -112.10M |
| FCF Per Share | -$1.66 |
Full Cash Flow StatementMargins
Gross margin is 46.23%, with operating and profit margins of 2.79% and -73.74%.
| Gross Margin | 46.23% |
| Operating Margin | 2.79% |
| Pretax Margin | -76.59% |
| Profit Margin | -73.74% |
| EBITDA Margin | 18.98% |
| EBIT Margin | 2.79% |
| FCF Margin | n/a |
Dividends & Yields
QuidelOrtho does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.60% |
| Shareholder Yield | -0.60% |
| Earnings Yield | -87.20% |
| FCF Yield | -4.76% |
Dividend DetailsAnalyst Forecast
The average price target for QuidelOrtho is $51.20, which is 49.18% higher than the current price. The consensus rating is "Buy".
| Price Target | $51.20 |
| Price Target Difference | 49.18% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 2.39% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
QuidelOrtho has an Altman Z-Score of 1.07 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.07 |
| Piotroski F-Score | 5 |